Invitrx Therapeutics Inc is categorized under Commercial Biotechnical Research in Irvine, CA and active since 2003.
Invitrx Therapeutics Inc was established in 2003, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Habib Torfi at the company’s single location by writing to 27 Mauchly # 206, Irvine, California CA 92618 or by phoning (949) 856-3142. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Invitrx Therapeutics Inc |
Contact Person: | Habib Torfi |
Address: | 27 Mauchly # 206, Irvine, California 92618 |
Phone Number: | (949) 856-3142 |
Website Address: | invitrxtherapeutics.squarespace.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2003 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 541711 |
Share This Business: |
Invitrx Therapeutics Inc was started in 2003 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Habib Torfi for inquiries that concern Invitrx Therapeutics Inc by calling the company number (949) 856-3142, as your correspondence is most welcome. Additionally, the physical location of the single location of Invitrx Therapeutics Inc can be found at the coordinates as well as the street address 27 Mauchly # 206 in Irvine, California 92618.
For its online presence, you may visit Invitrx Therapeutics Inc’s website at invitrxtherapeutics.squarespace.com and engage with its social media outlets through on Twitter and on Facebook.